Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

Treatments are available for dry AMD patients who also have geographic atrophy, but until the FDA's recent authorization of light therapy, those with dry AMD alone had no treatment options other than ...

Please provide your email address to receive an email when new articles are posted on . Female smokers had a greater visual acuity decline than male smokers. Hypertension, diabetes and number of ...

PARIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology ...

At least 20 million Americans ages 40 and older have age-related macular degeneration, and the threat posed by the vision-robbing condition will only grow larger as the population ages. Despite the ...

The evidence evaluating the effect of cataract surgery on the chances people with dry age-related macular degeneration (AMD) will convert to the more severe wet form of the condition has been uneven ...

Cognition Therapeutics, Inc. presented promising preclinical data at the ARVO conference, highlighting the potential of their drug candidate zervimesine (CT1812) to protect retinal pigment epithelial ...

New York, USA, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape | ...

If you’re over the age of 60, you may have noticed changes in your vision as you’ve gotten older. You might wonder which vision problems are normal, though, and which ones signify that you’re ...

In July 2025, Novartis Pharmaceuticals conducted a study is to assess the effect of Iptacopan to prevent conversion of early ...

Instant coffee is enjoying a nostalgic comeback among younger drinkers — yet new research warns the retro favorite may pose an unexpected risk for eye health. Developed in the early 20th century and ...